|
Number of cases
|
7
|
92
|
55
|
16
|
21
|
31
|
|
Median age (range) (year)
|
40 (20–54)
|
52 (21–89)
|
39 (14–75)
|
32 (16–72)
|
44 (21–79)
|
50 (13–77)
|
|
B symptoms
|
5 (100)
|
36 (39)
|
19 (35)
|
11 (69)
|
7 (33)
|
10 (32)
|
|
Ulceration
|
0 (0)
|
NR
|
55 (100)
|
7 (44)
|
NR
|
12 (39)
|
|
Concomitant diseases
|
5 (100)
|
NR
|
NR
|
NR
|
NR
|
NR
|
|
Pleomorphic
|
5 (83)
|
NR
|
42 (76)
|
13 (81)
|
NR
|
8 (26)
|
|
Number of CD30 + cases
|
4 (67)
|
36 (39)
|
13 (41)
|
2 (15)
|
5 (31)
|
NR
|
|
Median CD30 expression, % (range)
|
62.5 (50–80)
|
NR
|
NR
|
NR
|
NR
|
NR
|
|
Median Ki-67 index, % (range)
|
80 (70–95)
|
NR
|
70 (50–90)
|
60 (NR)
|
80 (50–90)
|
60 (30–80)
|
|
TR gene rearrangement (monoclonal/polyclonal)
|
3 (60)
|
35 (38)
|
9 (53)
|
0 (0)
|
NR
|
1 (17)
|
|
Median survival (range) (month)
|
5 (1–9)
|
19.2 (NR)
|
14 (1–56)
|
7 (2–20)
|
15.3 (0.5–87)
|
9 (1–104)
|
